John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Hooker Furnishings Corp
HOFT
$150M
| $1.3M | ﹤0.01% |
+68,797
| New | +$1.47M |
|
1552
LiveRamp
RAMP
$2.29B
| $1.3M | ﹤0.01% |
+34,854
| New | +$1.46M |
|
1553
Titan Machinery
TITN
$450M
| $1.3M | ﹤0.01% |
46,055
-27,496
| -37% | -$834K |
|
|
CIO
1554
DELISTED
City Office REIT
CIO
| $1.3M | ﹤0.01% |
73,488
-67,731
| -48% | -$1.22M |
|
1555
Great Southern Bancorp
GSBC
$858M
| $1.3M | ﹤0.01% |
21,996
+6,758
| +44% | +$407K |
|
1556
Marcus & Millichap
MMI
$1.22B
| $1.3M | ﹤0.01% |
24,626
+11,426
| +87% | +$547K |
|
1557
CEVA Inc
CEVA
$756M
| $1.3M | ﹤0.01% |
31,886
-24,415
| -43% | -$949K |
|
|
RTL
1558
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $1.3M | ﹤0.01% |
163,875
-428,488
| -72% | -$3.47M |
|
1559
RenaissanceRe
RNR
$13.6B
| $1.29M | ﹤0.01% |
+8,144
| New | +$1.27M |
|
|
INBX
1560
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.29M | ﹤0.01% |
+57,773
| New | +$1.47M |
|
|
MCHB
1561
Mechanics Bancorp
MCHB
$3.56B
| $1.29M | ﹤0.01% |
27,141
-47,328
| -64% | -$2.42M |
|
1562
Vericel Corp
VCEL
$2.2B
| $1.28M | ﹤0.01% |
33,568
-58,795
| -64% | -$2.12M |
|
|
EPZM
1563
DELISTED
Epizyme, Inc
EPZM
| $1.28M | ﹤0.01% |
1,115,516
+92,889
| +9% | +$151K |
|
1564
Argan
AGX
$6.3B
| $1.28M | ﹤0.01% |
31,570
+5,646
| +22% | +$221K |
|
1565
Nurix Therapeutics
NRIX
$2.79B
| $1.28M | ﹤0.01% |
+91,335
| New | +$1.62M |
|
|
CHCT
1566
Community Healthcare Trust
CHCT
$426M
| $1.28M | ﹤0.01% |
+30,297
| New | +$1.31M |
|
|
RMO
1567
DELISTED
Romeo Power, Inc.
RMO
| $1.27M | ﹤0.01% |
+854,910
| New | +$1.8M |
|
|
USAK
1568
DELISTED
USA Truck Inc
USAK
| $1.27M | ﹤0.01% |
+61,779
| New | +$1.35M |
|
1569
Cousins Properties
CUZ
$4.93B
| $1.27M | ﹤0.01% |
+31,561
| New | +$1.24M |
|
1570
HF Sinclair
DINO
$16.8B
| $1.27M | ﹤0.01% |
31,903
-1,050,066
| -97% | -$36.9M |
|
1571
Gulfport Energy Corp
GPOR
$3.05B
| $1.27M | ﹤0.01% |
+14,133
| New | +$1.02M |
|
|
MPT
1572
Medical Properties Trust
MPT
$2.44B
| $1.27M | ﹤0.01% |
+60,009
| New | +$1.29M |
|
1573
Lincoln Educational Services
LINC
$808M
| $1.27M | ﹤0.01% |
177,210
+40,577
| +30% | +$294K |
|
1574
Walt Disney
DIS
$192B
| $1.26M | ﹤0.01% |
+9,200
| New | +$1.33M |
|
1575
ANI Pharmaceuticals
ANIP
$1.72B
| $1.26M | ﹤0.01% |
44,863
-66,617
| -60% | -$2.48M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.